Informations sur le produit
Nom :
AG 494
Synonymes :
- (2E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-phenyl-2-propenamide
- (2E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-phenylacrylamide
- (2E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-phenylprop-2-enamide
- 2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N-phenyl-, (2E)-
- 2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N-phenyl-, (E)-
- Ag 494
- Tyrphostin AG 494
Description :
AG 494 is a pharmaceutical preparation that is used to treat diabetic neuropathy. AG 494 is a growth factor that activates the caco-2 cells. It also has been shown to have an anti-inflammatory effect on inflammatory diseases, such as Crohn's disease and ulcerative colitis. AG 494 is also a pharmacological agent for the treatment of inflammatory bowel disease and cancer. AG 494 inhibits lipid kinase activity, thereby inhibiting the production of lipids in cancer cells, which may lead to cell death by apoptosis or necrosis. In addition, AG 494 is a monoclonal antibody that targets the toll-like receptor 4 (TLR-4) pathway in cancer cells and suppresses their growth.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
280.28 g/mol
Formule :
C16H12N2O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
